|
|
|
|
|
|
|
Home
>
Scholars
>
Henry G. Grabowski
 (2)
|
Sunday, November 22, 2009
|
| |
|
|
|
SCHOLARS &
FELLOWS
Henry G. Grabowski
Adjunct Scholar
Duke University
Contact
E-mail: grabow@econ.duke.edu
Phone: 919-660-1839
Biography
Experience
Education
As Congress considers legislation that would allow imitative biological products, known as "biosimilars," to rely on the safety and efficacy data of original innovators, it must ensure that any provisions passed will foster, not stifle, discovery.
Events
U.S. Markets for Vaccines: Characteristics, Case Studies, and Controversies
May 8, 2009
Ernst R. Berndt and Anjli C. Warner discuss their new book, U.S. Markets for Vaccines: Characteristics, Case Studies, and Controversies.
What Should Congress Do about Generic or Follow-On Biologic Drugs?
June 11, 2007
Politics, Policy, and Progress in Health Care
December 11, 2002
|
|
|
|
|
|
|
|
EMAIL
PRINT
SAVE
